All In MedTech

Device Trial Radar · NCT05156112

OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit

Examining Early Intervention Obstructive Sleep Apnea Treatment on Long-Term Outcomes in Veterans With SUD/PTSD in a Residential Treatment Program

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 194 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

194

Planned (sponsor's estimate)

Start

Jan 2, 2023

Primary completion

May 31, 2027

Study completion May 31, 2027

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
First posted
Dec 14, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional impairment than having either disorder alone. This is especially true in residential settings where both disorders are more severe than outpatient settings. Obstructive sleep apnea (OSA) is highly comorbid with both disorders and untreated OSA is associated with worse functional impairment across multiple domains, worse quality of life, worse PTSD, higher suicidal ideation, and higher substance use and relapse rates. Treating OSA with evidence-based positive airway pressure (PAP) in Veterans with SUD/PTSD on a residential unit is a logical way to maximize treatment adherence and treatment outcomes. This study compares OSA treatment while on a SUD/PTSD residential unit to a waitlist control group. The investigators hypothesize that treating OSA on the residential unit, compared to the waitlist control, will have better functional, SUD, and PTSD outcomes.

Conditions

  • Post Traumatic Stress Disorder
  • Obstructive Sleep Apnea
  • Substance Use Disorder
  • Residential Treatment Program

Interventions

  • Positive Airway Pressure DeviceDevice

    Each PAP treatment initiation meeting will include 1) mask fitting; 2) psycho-education to what to expect and reviewing PAP machine problem solving; and 3) setting up correct PAP treatment (e.g., auto PAP or in rare conditions, bi-level PAP).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)Time frame: Baseline, Post-SARRTP Unit (28 Days), 3-Month Follow up (90 Days)
  2. Change in Timeline Follow-Back (TLFB) % days drinking/using in last 90 daysTime frame: Baseline, 3-Month Follow up (90 Days)
  3. Change in Clinician Administered PTSD Scale (CAPS-5)Time frame: Baseline, Post-SARRTP Unit (28 Days), 3-Month Follow up (90 Days)

1 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • VA San Diego Healthcare System, San Diego, CA

    San Diego, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.